Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

EuBiologics receives IND approval in Korea for its COVID-19 vaccine candidate

Jan. 22, 2021

c2H2/c3C1, a two-MAb cocktail with high therapeutic efficacy against SARS-CoV-2 infections

Jan. 21, 2021

Merck & Co. discovers antituberculosis compounds

Jan. 21, 2021

Adamis submits IND to the FDA for tempol as treatment of COVID-19

Jan. 21, 2021

Gritstone develops second-generation vaccine against SARS-CoV-2

Jan. 21, 2021

Structure-based multivalent nanobodies neutralize SARS-CoV-2 and prevent viral escape

Jan. 21, 2021

Aptorum cleared to begin phase I study in Canada with ALS-4 for S. aureus infections

Jan. 20, 2021

Gemcitabine can be repurposed as anti-HEV agent, in particular for HEV-infected cancer patients

Jan. 20, 2021

Ivermectin found useful in patients with nonsevere COVID-19 disease

Jan. 20, 2021

ConserV and Lawrence Livermore National Laboratory collaborate on broad-spectrum coronavirus vaccine

Jan. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...